metabolomics was further used to determine the temporal effects of the therapeutic intervention of grafting stem cell-derived retinal pigment epithelium (RPE) in dystrophic retinas, which significantly prevented photoreceptor atrophy in our previous studies. The result revealed that lipid levels such as phosphatidylethanolamine in eyes were restored in those animals receiving the RPE grafts. In conclusion, this study provides insight into the metabolomics of retinal degeneration, and further understanding of the efficacy of RPE transplantation.This article is part of the themed issue 'Quantitative mass spectrometry'.
BackgroundThe leading cause of central vision loss in industrialized countries is age-related macular degeneration (AMD), which could be caused by ageing, smoking and obesity [1][2][3]. AMD is caused by dysfunction or loss of a neighbouring transporting epithelium, i.e. the retinal pigment epithelium (RPE). RPE cells physically contact the tips of photoreceptors and provide critical metabolic support, recycling light-sensitive pigments required for vision. The photoreceptors are the most numerous and metabolically demanding cells in the retina; the RPE and photoreceptors are considered to be one functional unit due to their co-dependency [4]. The risk of AMD can be reduced through low-glucose and omega-6-enriched diets. Numerous small molecules such as polyunsaturated fatty acids (PUFAs), fatty acid primary amines and amides, amino acids, vitamin A analogues, phospholipids, oxidized species and lipofuscin pigments are enriched in the outer retina. Therefore, the correct balance of these metabolites may be critical for maintaining retinal homeostasis. A more complete understanding of metabolic pathways of retinal development and pathogenesis may be very useful for developing therapeutic interventions to prevent or slow disease progression. To date, no cure for the most common form of AMD, geographical atrophy or 'dry' AMD, has been identified, but it is possible that RPE transplantation could offer a promising therapeutic approach. We and others have shown that transplantation of healthy RPE cells is effective in preclinical studies to significantly, albeit transiently [5], promote photoreceptor survival in the face of RPE-mediated retinal degeneration [6][7][8][9][10]; clinical trials are underway to test the safety and efficacy of stem cell-derived RPE grafts in different types of retinal degeneration [11]. Whether the grafted RPE cells provide essential functional or trophic (or both) support remains unresolved. We have previously examined some of the functional effects of grafted RPE, but changes to the metabolome post transplantation have not been investigated. As retinal metabolism is greatly understudied, and the metabolic pathways that are most essential for vision and retinal homeostasis are not completely understood, we set out to perform a comprehensive metabolomic analysis of the retinal degeneration metabolome. Identification of important classes of metabolites that are important for pho...